Recombinant Human SLC1A3 Protein (Yeast)，His

SLC1A3, also known as EAAT1 (excitatory amino acid transporter 1), is a crucial glutamate transporter predominantly expressed in astrocytes within the central nervous system. It plays a vital role in maintaining glutamate homeostasis, preventing excitotoxicity, and regulating neurotransmission. Dysregulation of SLC1A3 has been implicated in various neurological disorders, including epilepsy, Alzheimer's disease, and Huntington's disease. The study of SLC1A3 is essential for understanding its functional mechanisms and potential as a therapeutic target. The recombinant expression of SLC1A3 in heterologous systems allows for detailed structural and functional characterization, facilitating the exploration of its substrate binding and transport properties. Advances in recombinant protein technology, such as the use of eukaryotic expression systems, have enabled researchers to produce functional and properly folded SLC1A3 proteins, advancing our understanding of its role in neurobiology. Additionally, structural studies, including X-ray crystallography and cryo-electron microscopy, are paving the way for insights into the transport cycle and the transporter's interaction with different ligands, potentially informing drug design aimed at modulating its activity. Overall, the research on SLC1A3 recombinant protein not only provides valuable information about glutamate transport but also opens avenues for novel therapeutic approaches in neurodegenerative and psychiatric disorders.